MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$64,586K Inventory$39,931K Accounts receivable$19,524K Prepaid expenses andother current assets$17,432K Total current assets$141,473K Operating leaseright-of-use assets$25,671K Property and equipment,net$10,472K Restricted cash$4,907K Other assets -noncurrent$2,092K Capitalized software, net$1,836K Total assets$186,451K Accumulated deficit-$190,100K Accumulated othercomprehensive loss-$80K Total liabilities,convertible preferred stock...$186,451K Total stockholders'deficit-$178,071K Additional paid-in capital$12,108K Common stock$1K Convertible preferred stock$234,996K Total liabilities$129,526K Convertible note$65,094K Long-term operating leaseliabilities$28,979K Total currentliabilities$24,048K Term debt$9,877K Other noncurrentliabilities$1,197K Warrant liabilities$331K Accrued and othercurrent liabilities$16,814K Accounts payable$5,635K Short-term operating leaseliabilities$1,599K
Balance Sheet

Alamar Biosciences, Inc. (ALMR)

Alamar Biosciences, Inc. (ALMR)

source: myfinsight.com